期刊文献+

子宫内膜癌组织中胰岛素受体底物1的表达与活化及其临床意义 被引量:6

Expression and activation of insulin receptor substrate-I in endometrial carcinoma
原文传递
导出
摘要 目的研究子宫内膜癌组织中胰岛素受体底物1(IRS-1)mRNA、蛋白的表达水平及酪氨酸磷酸化程度,并探讨其临床意义。方法选择63例子宫内膜癌(内膜癌组)、21例子宫内膜不典型增生(不典型增生组)及22例正常子宫内膜(正常内膜组)患者进入本研究。收集其临床病理资料,酶联免疫法检测空腹血清胰岛素C肽水平,RT-PCR技术和蛋白印迹法分别检测子宫内膜组织中IRS-1 mRNA及蛋白的相对表达量,免疫共沉淀法检测IRS-1酪氨酸磷酸化程度。结果内膜癌组患者血清C肽水平为(3.2±1.1)μg/L,高于正常内膜组[(2.5±0.7)μg/L],两组比较,差异有统计学意义(P=0.007)。内膜癌、不典型增生及正常内膜组IRS-1 mRNA、蛋白的相对表达量比较,差异均无统计学意义(F=0.695、0.003,P=0.502、0.997)。内膜癌组IRS-1酪氨酸磷酸化程度[(62±36)%]高于不典型增生及正常内膜组[分别为(53±34)%、(35±33)%],分别比较,差异均有统计学意义(P=0.048、0.002);不典型增生组与正常内膜组比较,差异也有统计学意义(P=0.045)。子宫内膜样腺癌患者IRS-1酪氨酸磷酸化程度[(69±33)%]高于非内膜样癌[(34±31)%],两者比较,差异有统计学意义(t=2.300,P=0.025)。高手术病理分期、细胞分化不良、深肌层浸润及盆腔淋巴结转移者IRS-1酪氨酸磷酸化程度增高(P均〈0.05)。子宫内膜组织中IRS-1酪氨酸磷酸化程度与空腹血清C肽水平呈正相关关系(r=0.491,P=0.001)。结论子宫内膜癌组织中IRS-1的表达无明显变化,但存在IRS-1酪氨酸磷酸化程度增加,并与手术病理分期高、细胞分化不良、深肌层浸润及盆腔淋巴结转移等不良的临床病理特征相关。 Objective To investigate the mRNA, protein expression and tyrosine phosphorylation of insulin receptor sttbstrate-1 (IRS-1) in endometrial carcinoma. Methods Sixty-three endometrial carcinoma (EC) patients, 21 endometrial atypical hyperplasia (AHE) patients and 22 normal control ( NE ) entered this study. Their clinical information were collected. Fasting serum C-peptide concentration was measured. Expression of IRS-1 in endometrium was examined by RT-PCR and western blot. Immunoprecipitation was used to measure the tyrosine phosphorylation of IRS-1. Results C-peptide concentration in EC group was higher than that in NE group [ ( 3.2 ± 1.1 ) vs (2. 5 ± 0. 7 ) μg/L, P = 0. 007]. There were no significant differences in IRS-1 mRNA and protein expression among the three groups. Tyrosine phosphorylation of IRS-1 in EC group [ (62 ± 36) % ] was higher than that in AHE and NE groups [(53 ±34)% and (35 ±33)%; P =0.048, 0.002]. IRS-1 activation in AHE group was also higher than normal control ( P = 0. 045 ). IRS-1 activation in endometrioid carcinoma [ ( 69 ± 33 ) % ] was higher than that in other histological types [ ( 34 ± 31 )% ; t = 2. 300, P = 0. 025 ] . IRS-1 tyrosine phosphorylation was significantly higher in patients with advanced stage, high grade, deep myometrial invasion and pelvic lymph node metastasis. IRS-1 activation in endometrium was positively correlated with fasting serum C-peptide concentration ( r = 0. 491, P = 0. 001 ). Conclusions There is excessive activation of IRS-1 in endometrial carcinoma and atypical hyperplasia. Activation of IRS-1 in endometrial carcinoma is related with poor clinical-pathologic features and may be a prognostic predictor for this tumor. Over-activation of IRS-1 may be an intermediate event linking the hyperinsulinemia and endometrial carcinoma.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2008年第6期437-441,共5页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金(30471810)
关键词 子宫内膜肿瘤 磷蛋白类 酪氨酸 磷酰化 Endometrial neoplasms Phosphoproteins Tyrosine Phosphorylation
  • 相关文献

参考文献11

  • 1Petridou E, Koukoulomatis P, Alexe DM, et al. Endometrial cancer and the IGF system: a ease-control study in Greece. Oneology, 2003,64 :341-345.
  • 2Han CH, Cho JY, Moon JT, et al. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Oncol Rep, 2006,16 : 1205-1210.
  • 3Lee AV, Jackson JG, Gooeh JL, et al. Enhancement of insulinlike growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endoerinol, 1999, 13 : 787-796.
  • 4Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome. Am J Physiol Endocrinol Metab,2001, 281:392-399.
  • 5Dalmizrak O, Wu A, Chen J, et al. Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer celia Cancer Res, 2007,67:2124-2130.
  • 6Byron SA, Horwitz KB, Richer JK, et al. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer, 2006,95 : 1220-1228.
  • 7Dearth RK, Cui X, Kim HJ, et aL Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 ( IRS-1 ) or IRS-2. Mol Cell Biol, 2006,26:9302-9314.
  • 8Koda M, Sulkowska M, Kanczuga-Koda L, et al. Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J Clin Pathol, 2005,58:645-649.
  • 9薛凤霞,焦书竹.子宫内膜癌病因学研究进展[J].中国实用妇科与产科杂志,2001,17(11):643-645. 被引量:13
  • 10赵敬,薛凤霞,华绍芳,张丽志.胰岛素对子宫内膜癌细胞增殖和凋亡的影响[J].中华妇产科杂志,2007,42(10):696-700. 被引量:20

二级参考文献13

  • 1[1]Sherman ME,Sturgeon S,Brinton LA,et al.Risk factors and hormon levels in pat ients with serous and endometrioid uterine carcinomas.Mod Pathol,1997,10(10):963
  • 2[2]Dunaif A.Insulin resistance and the polycystic ovary syndrome:mechanism and i mplications for pathogenesis.Endocr Rev,1997,18(6):774
  • 3[3]Pike MC,Peters RK,Cozen W,et al.Estrogen progestin replacement therapy and en dometrial cancer.J Natl Cancer Inst,1997,89(15):1110
  • 4[4]Deligdisch L.Hormonal pathology of endometrium.Mod Pathol,2000,13(3):285
  • 5[5]Sherman ME.Theories of endometrial carcinogenesis:a multidisciplinary approac h.Mod Pathol,2000,13(3):295
  • 6Sehiel R, Beltschikow W, Steiner T, et al. Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol, 2006, 28 : 169-175.
  • 7Musi N, Goodyear LJ. Insulin resistance and improvements in signal transduction. Endocrine, 2006, 29:73-80.
  • 8Schairer C, Hill D, Sturgeon SR, et al. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer, 2004, 108 : 773-779.
  • 9Mawson A, Lai A, Carroll JS, et al. Estrogen and insulin/IGF-I cooperatively stimulate cell progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin DI. Mol Cell Endocrinol, 2005, 229 : 161-173.
  • 10Cust AE, Allen NE, Rinaldi S, et al. Serum levels of C-peptide, IGFBP-I and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer, 2007, 120:2656-2664.

共引文献45

同被引文献97

  • 1李艳,郎景和.基质金属蛋白酶9及其组织抑制剂1在子宫内膜异位症组织中的表达[J].中华妇产科杂志,2006,41(1):30-33. 被引量:27
  • 2Lee RC,Feinbaum RL,Ambros V.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin14.Cell,1993,75:843-854.
  • 3Inui M,Martello G,Piccolo S.MicroRNA control of signal transduction.Nat Rev Mol Cell Biol,2010,11:252-263.
  • 4Teague EM,Print CG,Hull ML.The role of microRNAs in endometriosis and associated reproductive conditions.Hum Reprod Update,2010,16:142-165.
  • 5Esquela-Kerscher A,Slack FJ.Oncomirs-microRNAs with a role in cancer.Nat Rev Cancer,2006,6:259-269.
  • 6Cannell IG,Kong YW,Bushell M.How do microRNAs regulate gene expression? Biochem Soc Trans,2008,36:1224-1231.
  • 7Sampson JA.Perforating haemorrhagic (chocolate) cysts of the ovary:their importance and especially their relation to pelvic adenomas of endometrial type.Arch Surg,1921,3:245-323.
  • 8Hull ML,Escareno CR,Godsland JM,et al.Endometrialperitoneal interactions during endometriotic lesion establishment.Am J Pathol,2008,173:700-715.
  • 9Chen R,Alvero AB,Silasi DA,et al.Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.Oncogene,2008,27:4712-4723.
  • 10Ohlsson Teague EM,Van der Hoek KH,Van der Hoek MB,et al.MicroRNA-regulated pathways associated with endometriosis.Mol Endocrinol,2009,23:265-275.

引证文献6

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部